- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06171932
Comparison Of Efficacy Of Hydrocortisone And Methyl Prednisolone In Acute Severe Asthma
COMPARISON OF EFFICACY OF HYDROCORTISONE AND METHYLPREDNISOLONE IN ACUTE SEVERE ASTHMA
In this study Investigator will compare the efficacy of hydrocortisone and methyl prednisolone in acute severe asthma that will lead to final result and beneficial effects that will help in early resoloution of symptoms and help in preventing recurrence
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
investigator will compare the efficacy of hydrocortisone v/s methylprednisolone in management of patients presented with acute severe asthma in emergency.
A local study was conducted in 2009, after that there is a big research gap exists at national level although international literature is available on the same but it can not be generalized to our population due to socio, geographic and economic differences so there is dire need to conduct this study this gives a strong rationale to implement in our settings
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan, 09323
- Zia ud din hospital university
-
Karachi, Sindh, Pakistan, 09323
- Zia ud din university hospital
-
Karachi, Sindh, Pakistan
- Zia ud din university hospitals
-
Karachi, Sindh, Pakistan
- Zia ud din university
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Either Gender (18 to 50 years old)
- Patient presenting to emergency department with acute severe asthma
Exclusion Criteria:
- Patients with critical illness or pregnant females. .Patient treated other than hydrocortisone and methylprednisolone. .Patients not willing to participate in study.
- Life threatening asthma
- Near fatal asthm
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
HYDROCORTISONE
Group A will comprise of 30 patients will be treated with 200 mg hydrocortisone followed by 3 doses of hydrocortisone 100 mg 6 hours apart for next 24hrs
|
|
METHYLPREDNISOLONE
Group B will be treated with methylprednisolone 125 mg stat
|
No intervention required
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Spirometry
Time Frame: 24 hours
|
Above will be check on arrival of patient to Emergency and post Managment
|
24 hours
|
Blood pressures
Time Frame: 24 hours
|
Vital signs at initial presentation and post managment will be recorded Blood pressure in mm HG will be recorded
|
24 hours
|
Respiratory rate
Time Frame: 24 hours
|
Respiratory rate at arrival and post managment will be considered Respiratory rate in Breaths/min
|
24 hours
|
Heart rate
Time Frame: 24 hours
|
Heart rate beats/min will be checked
|
24 hours
|
PEAK EXPIRATORY FLOW RATE
Time Frame: 24 hours
|
it wil be checked on arrival and post managment in Peak Expiratory Flow rate (force expiratory volume in 1 second and force vital capacity )will be examined
|
24 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Inayat ur Rehman, MD ER, zia ud din university karachi
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Respiratory Tract Diseases
- Immune System Diseases
- Lung Diseases
- Hypersensitivity, Immediate
- Bronchial Diseases
- Lung Diseases, Obstructive
- Respiratory Hypersensitivity
- Hypersensitivity
- Asthma
- Status Asthmaticus
- Physiological Effects of Drugs
- Autonomic Agents
- Peripheral Nervous System Agents
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Antiemetics
- Gastrointestinal Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Neuroprotective Agents
- Protective Agents
- Prednisolone
- Methylprednisolone Acetate
- Methylprednisolone
- Methylprednisolone Hemisuccinate
- Prednisolone acetate
- Prednisolone hemisuccinate
- Prednisolone phosphate
- Hydrocortisone
Other Study ID Numbers
- Zia ud din university karachi
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma Acute
-
Vanderbilt University Medical CenterNot yet recruitingAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
University of MonastirUnknownAcute AsthmaTunisia
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
University of British ColumbiaPost Graduate Institute of Medical Education and Research, ChandigarhUnknownAsthma in Children | Asthma Acute
-
Tufts Medical CenterCompleted
-
Istanbul University - Cerrahpasa (IUC)CompletedAsthma | Asthma in Children | Asthma Attack | Asthma AcuteTurkey
-
University of East AngliaCompleted
-
MetroHealth Medical CenterGlaxoSmithKlineCompleted
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Universidade Federal de PernambucoCompleted
Clinical Trials on Methylprednisolone,
-
Rennes University HospitalUnknownMultiple Sclerosis, Relapsing-RemittingFrance
-
Chang Gung Memorial HospitalRecruitingMucocutaneous Lymph Node SyndromeTaiwan
-
Fred LublinPfizer; National Multiple Sclerosis SocietyTerminatedMultiple SclerosisUnited States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Universidad Nacional Autonoma de MexicoInstituto Nacional de Neurología y NeurocirugíaEnrolling by invitationMethylprednisolone | Intranasal Administration | Patients With an Active Multiple Sclerosis RelapseMexico
-
LEO PharmaBayerCompleted
-
Assiut UniversityCompleted
-
University of Colorado, DenverUniversity of Pennsylvania; MallinckrodtTerminatedMultiple SclerosisUnited States
-
Fundação de Medicina Tropical Dr. Heitor Vieira...CompletedSARS-CoV Infection | Severe Acute Respiratory Syndrome (SARS) PneumoniaBrazil
-
Peking University People's HospitalBeijing HospitalUnknownImmune Thrombocytopenia